Predicting hyperprogressive disease in patients with advanced hepatocellular carcinoma treated with anti-programmed cell death 1 therapy

Predicting hyperprogressive disease in patients with advanced hepatocellular carcinoma treated with anti-programmed cell death 1 therapy

Background: Hyperprogressive disease (HPD) is a new progressive pattern in patients with advanced hepatocellular carcinoma (HCC) treated with programmed cell death 1 (PD-1) inhibitors. We aimed to investigate risk factors associated with HPD in advanced HCC patients undergoing anti-PD-1 therapy. Met...

Full description

Bibliographic Details
Main Authors: Lu Zhang, Lingeng Wu, Qiuying Chen, Bin Zhang, Jing Liu, Shuyi Liu, Xiaokai Mo, Minmin Li, Zhuozhi Chen, Luyan Chen, Jingjing You, Zhe Jin, Xudong Chen, Zejian Zhou, Shuixing Zhang
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:EClinicalMedicine
Subjects:
Hyperprogressive disease
Programmed cell death 1
Immune checkpoint inhibitors
Hepatocellular carcinoma
Online Access:http://www.sciencedirect.com/science/article/pii/S258953702030417X

Internet

http://www.sciencedirect.com/science/article/pii/S258953702030417X

Similar Items